On January 16, 2026, Mistral Inc. and UVision Inc. announced that the HERO-90 loitering munition had been selected by the U.S. Army’s Program Executive Office Soldier to participate in the Low Altitude Stalking and Strike Ordnance (LASSO) program. The decision places the system inside an accelerated Army evaluation effort aimed at providing dismounted units with a man-portable, precision anti-armor capability. While the announcement does not represent a procurement award, it signals that HERO-90 has entered a competitive and time-sensitive pathway where operational performance, integration readiness, and deliverability could shape future acquisition decisions. The move reflects the Army’s urgency to address capability gaps exposed by recent high-intensity conflicts and increasingly complex battlefield conditions. Read Full Defense News At This Link.
Home » Army »
Defence »
Military »
News »
World
» U.S. Army Selects Israeli HERO-90 Loitering Munition for Accelerated Infantry Anti-Armor Trials